Literature DB >> 20139986

Chromogranin A is an autoantigen in type 1 diabetes.

Brian D Stadinski1, Thomas Delong, Nichole Reisdorph, Richard Reisdorph, Roger L Powell, Michael Armstrong, Jon D Piganelli, Gene Barbour, Brenda Bradley, Frances Crawford, Philippa Marrack, Sushil K Mahata, John W Kappler, Kathryn Haskins.   

Abstract

Autoreactive CD4(+) T cells are involved in the pathogenesis of many autoimmune diseases, but the antigens that stimulate their responses have been difficult to identify and in most cases are not well defined. In the nonobese diabetic (NOD) mouse model of type 1 diabetes, we have identified the peptide WE14 from chromogranin A (ChgA) as the antigen for highly diabetogenic CD4(+) T cell clones. Peptide truncation and extension analysis shows that WE14 bound to the NOD mouse major histocompatibility complex class II molecule I-A(g7) in an atypical manner, occupying only the carboxy-terminal half of the I-A(g7) peptide-binding groove. This finding extends the list of T cell antigens in type 1 diabetes and supports the idea that autoreactive T cells respond to unusually presented self peptides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139986      PMCID: PMC3166626          DOI: 10.1038/ni.1844

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  44 in total

Review 1.  Chromogranin A and its derived peptides in the rat and porcine gastro-entero-pancreatic system. Expression, localization, and characterization.

Authors:  W J Curry; P Norlén; S C Barkatullah; C F Johnston; R Håkanson; J C Hutton
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones.

Authors:  B Bergman; J L McManaman; K Haskins
Journal:  J Autoimmun       Date:  2000-06       Impact factor: 7.094

3.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.

Authors:  A L Corper; T Stratmann; V Apostolopoulos; C A Scott; K C Garcia; A S Kang; I A Wilson; L Teyton
Journal:  Science       Date:  2000-04-21       Impact factor: 47.728

Review 4.  WE-14, a chromogranin a-derived neuropeptide.

Authors:  W J Curry; S C Barkatullah; A N Johansson; J G Quinn; P Norlen; C K Connolly; A P McCollum; C M McVicar
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

5.  Projection of an immunological self shadow within the thymus by the aire protein.

Authors:  Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis
Journal:  Science       Date:  2002-10-10       Impact factor: 47.728

6.  Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.

Authors:  V Judkowski; C Pinilla; K Schroder; L Tucker; N Sarvetnick; D B Wilson
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

Authors:  R R Latek; A Suri; S J Petzold; C A Nelson; O Kanagawa; E R Unanue; D H Fremont
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

8.  Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.

Authors:  Kenji Yoshida; Tracy Martin; Ken Yamamoto; Cathleen Dobbs; Christian Münz; Nobuhiro Kamikawaji; Naoko Nakano; Hans-Georg Rammensee; Takehiko Sasazuki; Kathryn Haskins; Hitoshi Kikutani
Journal:  Int Immunol       Date:  2002-12       Impact factor: 4.823

9.  The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.

Authors:  Paula Y Arnold; Nicole L La Gruta; Tim Miller; Kate M Vignali; P Scott Adams; David L Woodland; Dario A A Vignali
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au.

Authors:  Xiao-lin He; Caius Radu; John Sidney; Alessandro Sette; E Sally Ward; K Christopher Garcia
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

View more
  180 in total

1.  A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.

Authors:  Stephen T Ferris; Javier A Carrero; James F Mohan; Boris Calderon; Kenneth M Murphy; Emil R Unanue
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Authors:  Brian D Stadinski; Li Zhang; Frances Crawford; Philippa Marrack; George S Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 3.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 4.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

5.  Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.

Authors:  Suchitra Prasad; Adam P Kohm; Jeffrey S McMahon; Xunrong Luo; Stephen D Miller
Journal:  J Autoimmun       Date:  2012-05-28       Impact factor: 7.094

Review 6.  T cell epitopes and post-translationally modified epitopes in type 1 diabetes.

Authors:  John W McGinty; Meghan L Marré; Veronique Bajzik; Jon D Piganelli; Eddie A James
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

7.  Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cells.

Authors:  James M Gardner; Todd C Metzger; Eileen J McMahon; Byron B Au-Yeung; Anna K Krawisz; Wen Lu; Jeffrey D Price; Kellsey P Johannes; Ansuman T Satpathy; Kenneth M Murphy; Kristin V Tarbell; Arthur Weiss; Mark S Anderson
Journal:  Immunity       Date:  2013-08-29       Impact factor: 31.745

8.  Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.

Authors:  Rocky L Baker; Thomas Delong; Gene Barbour; Brenda Bradley; Maki Nakayama; Kathryn Haskins
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 9.  The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.

Authors:  Boris Calderon; Javier A Carrero; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2013-11-16       Impact factor: 7.486

10.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.